DERM Stock Analysis: Buy, Sell, or Hold?
DERM - Journey Medical Corporation Common Stock
$8.36
-0.09 (-1.07%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When DERM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
🚀 STRONG BUY: DERM shows excellent value with unusually cheap options (IV 22th percentile) and market pricing in only 2.3% annual growth despite strong fundamentals. High conviction opportunity.
🚀 STRONG BUY: DERM shows excellent value with unusually cheap options (IV 22th percentile) and market pricing in only 2.3% annual growth despite strong fundamentals. High conviction opportunity.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$8.84
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$5.49
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DERM is currently trading at $8.36, which is considered slightly high relative to its 30-day fair value range of $7.48 to $8.59. The stock's valuation (Forward PE: 33.5) is in line with its historical norms (31.3). At these levels, the market is pricing in 2.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DERM is in a uptrend. Immediate support is located at $7.66, while resistance sits at $9.55.
Market Sentiment: DERM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.50 (+59.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DERM is in a uptrend. Immediate support is located at $7.66, while resistance sits at $9.55.
Market Sentiment: DERM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (22th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $13.50 (+59.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$7.48 -
$8.59
Company Quality Score
60/100
(BUY)
Options IV Signal
22th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
81.5%
All Signals
- BULLISH: Options cheap (IV 22th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.8% below Wall St target ($13.50)
- NEUTRAL: Market pricing in 2.3% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$7.48 -
$8.59
Current vs Fair Value
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.70
(8.4%)
Support & Resistance Levels
Support Level
$7.66
Resistance Level
$9.56
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
33.47
Wall Street Target
$13.50
(+59.8%)
Revenue Growth (YoY)
20.5%
Profit Margin
-14.6%
Valuation Premium vs History
+2.3% premium
PE vs Historical
33.5 vs 31.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.3%
(market-implied from PE analysis)
1-Year Target
$8.64
(+2%)
2-Year Target
$8.84
(+5%)
3-Year Target
$9.05
(+7%)
3-Yr Target (if PE normalizes)
(PE: 33→31)
PE COMPRESSION
$8.46
(+0%)
Earnings growth offset by PE compression
Last updated: January 31, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DERM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$179 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$158 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$84 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
Advanced DERM Option Strategies
Professional options setups generated by AI based on today's DERM price and gamma walls.
